Captomer 50mg Tablet belongs to the class of medication called anticancer drugs used in the treatment of blood cancer. Blood cancer also known as leukaemia, is the cancer of blood cells. It causes excessive production of immature white blood cells by the bone marrow.

Captomer 50mg Tablet contains Mercaptopurine that works by interfering with the production of genetic material (DNA and RNA) in the cancer cells that are essential for growth, repair and multiplication of cells. Thus, Captomer 50mg Tablet stops multiplication of abnormal cells and leads to the growth of cells in an unbalanced way and causes the death of cells.

Take Captomer 50mg Tablet as prescribed by your doctor. You are advised to take Captomer 50mg Tablet for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience vomiting, nausea, low red blood cell count, loss of appetite, diarrhoea or inflammation of the mouth. Most of these side effects of Captomer 50mg Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are known to be allergic to Captomer 50mg Tablet or any other medicines, please tell your doctor. Avoid taking Captomer 50mg Tablet if you are pregnant or breastfeeding and consult a doctor. You are recommended to use effective contraceptive methods while using Captomer 50mg Tablet and for 3 months after completing the course of Captomer 50mg Tablet to prevent pregnancy. Captomer 50mg Tablet should be used with caution in children, especially in children below 6 years or with low body mass index as it may cause low blood sugar. Avoid excessive exposure to sunlight as Captomer 50mg Tablet may cause sensitivity to sunlight. You are advised to use a sunscreen with a high protection factor and wear protective clothing while going out. Captomer 50mg Tablet may increase the risk of a serious condition called macrophage activation syndrome (over activation of white blood cells associated with inflammation), especially in people with arthritis.

Captomer 50mg Tablet contains Mercaptopurine, an anticancer drug used to treat blood cancer. Captomer 50mg Tablet interferes with the production of genetic material (DNA and RNA) in the cancer cells essential for growth, repair and multiplication of cells. Thus, Captomer 50mg Tablet stops multiplication of abnormal cells and leads to cell's growth in an unbalanced way and causes the death of cells. 

If you are allergic to Captomer 50mg Tablet or any other medicines, please tell your doctor. Avoid taking Captomer 50mg Tablet if you are pregnant or breastfeeding and consult a doctor. You are recommended to use effective contraceptive methods while using Captomer 50mg Tablet and 3 months after completing the course of Captomer 50mg Tablet to prevent pregnancy. Captomer 50mg Tablet should be used with caution in children, especially in children below 6 years or with low body mass index as it may cause low blood sugar. Captomer 50mg Tablet may increase the risk of infections. Therefore, consult your doctor if you notice any infection signs such as urinary problems, sore throat or mouth. Avoid excessive exposure to sunlight as Captomer 50mg Tablet may cause sensitivity to sunlight. You are advised to use a sunscreen with a high protection factor and wear protective clothing while going out. Captomer 50mg Tablet may increase the risk of a serious condition called macrophage activation syndrome (over activation of white blood cells associated with inflammation), especially in people with arthritis. If you are about to receive any vaccinations, inform your doctor that you are taking Captomer 50mg Tablet to cause infections. 

• Regular blood and urine tests are recommended while taking Captomer 50mg Tablet to monitor the number of red blood cells, platelets, white blood cells, uric acid levels, kidney or liver functioning.
• Do not receive any vaccination during treatment without your doctor's approval while taking Captomer 50mg Tablet.